title: Hepatitis B and C in the Syrian Arab Republic: a review.
abstract: This paper reviews the epidemiology and determinants of hepatitis B and C in the Syrian Arab Republic as well as their treatment and prevention. A systematic search of Medline, PubMed and Index Medicus for the Eastern Mediterranean Region was carried out in addition to a review of grey literature and relevant datasets in the Syrian Arab Republic. Low to low-intermediate levels of endemicity of both infections were noted at the national level. However, striking geographic differences and high prevalence among high-risk groups were noticeable. As a result of data limitations, further research is needed, and a national control strategy to combat hepatitis B and C in the Syrian Arab Republic should be developed, especially during the current conflict.
authors.affiliation: Damascus University, Damascus, Syrian Arab Republic.
authors.forename: H
authors.initials: H
authors.lastname: Bashour
authors.affiliation: WHO Country Office, Damascus, Syrian Arab Republic.
authors.forename: G
authors.initials: G
authors.lastname: Muhjazi
mesh_terms: D006509:Hepatitis B / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control; D006526:Hepatitis C / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control; D006801:Humans; D015995:Prevalence; D013593:Syria / Q000453:epidemiology